Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Neoplasia (New York, N.Y.)|August 22, 2024
Characterization of circulating tumor cells in patients with metastatic bladder cancer utilizing functionalized microfluidicsZeqi Niu, Molly Kozminsky, Kathleen C Day, et al.
Bladder Cancer (Amsterdam, Netherlands)|February 13, 2018
Molecular Correlates of <i>In Vitro</i> Responses to Dacomitinib and Afatinib in Bladder CancerShuzo Tamura, Yin Wang, Brendan Veeneman, et al.
Nature Protocols|January 27, 2019
A surgical orthotopic approach for studying the invasive progression of human bladder cancerGuadalupe Lorenzatti Hiles, Angelica L Cates, Layla El-Sawy, et al.
Oncogene|January 16, 2019
ATDC mediates a TP63-regulated basal cancer invasive programPhillip L Palmbos, Yin Wang, Armand Bankhead Iii, et al.
Cancer|May 8, 2014
A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinomaMaha Hussain, Stephanie Daignault, Neeraj Agarwal, et al.
Cancer Research|October 30, 2016
HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to BoneKathleen C Day, Guadalupe Lorenzatti Hiles, Molly Kozminsky, et al.
European Urology|July 24, 2018
Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic ImplicationsDaniel H Hovelson, Aaron M Udager, Andrew S McDaniel, et al.
The Journal of Biological Chemistry|August 3, 2025
The molecular mechanism of ambrosin-induced cytotoxicity of human breast cancer and bladder cancer cellsLayla El-Sawy, John R Rubin, Luke Broses, et al.
Cancer Research|February 28, 2013
HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumabSuthinee Ithimakin, Kathleen C Day, Fayaz Malik, et al.
European Urology|August 18, 2024
Integrative Drug Screening and Multiomic Characterization of Patient-derived Bladder Cancer Organoids Reveal Novel Molecular Correlates of Gemcitabine ResponseNathan M Merrill, Samuel D Kaffenberger, Liwei Bao, et al.
Pageof 4